IVD Medical Ends Strategic Partnership with Japan’s Sysmex in Coagulation Products

Fineline Cube
0 Min Read
Summarize with AI

IVD Medical Holding Ltd (HKG: 1931), a China-based in vitro diagnostic (IVD) specialist, has announced the termination of its strategic partnership agreement with Japan’s Sysmex Corporation concerning its coagulation product business.

- Advertisement -

The partnership, initially established in November 2023, involved Sysmex investing in IVD Medical’s subsidiary, thereby becoming a shareholder and forming a long-term distribution relationship. Financial terms of the agreement were not disclosed.- Flcube.com

Share This Article